CollPlant Biotechnologies
CLGN
12 hedge funds and large institutions have $6.79M invested in CollPlant Biotechnologies in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 3 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0.22% less ownership
Funds ownership: 1.3% → 1.08% (-0.22%)
8% less capital invested
Capital invested by funds: $7.39M → $6.79M (-$599K)
14% less funds holding
Funds holding: 14 → 12 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SDJVC
St. Denis J. Villere & Co
New Orleans,
Louisiana
|
+$465K |
| 2 |
BEI
Benjamin Edwards Inc
Clayton,
Missouri
|
+$117K |
| 3 |
AE
AMH Equity
Great Neck,
New York
|
+$115K |
| 4 |
Pathstone Holdings
Englewood,
New Jersey
|
+$83.2K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$23.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Pinnacle Associates
New York
|
-$471K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$21.9K |
| 3 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
-$17.9K |
| 4 |
RWMG
Redwood Wealth Management Group
Medford,
New Jersey
|
-$6.51K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$30 |
CLGN Hedge Fund Activity: Q3 2024 in Review
12 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in CollPlant Biotechnologies (CLGN) for Q3 2024, worth a combined $6.79M — down 8.1% from $7.39M a quarter earlier.
Fund positioning in CLGN was balanced in Q3 2024: 3 funds opened new positions, 3 closed out, 4 added to existing stakes and 2 trimmed.
The largest buyer was St. Denis J. Villere & Co, adding an estimated $465K. The largest seller was Pinnacle Associates, cutting an estimated $471K.
- 12 institutional investors held CollPlant Biotechnologies (CLGN) as of Q3 2024, down from 14 in Q2 2024.
- Funds reported $6.79M of CollPlant Biotechnologies stock for Q3 2024, down 8.1% quarter-over-quarter.
- 3 funds opened new CollPlant Biotechnologies positions in Q3 2024 and 3 closed out, a net change of 0 holders.
- The largest CollPlant Biotechnologies buyer in Q3 2024 was St. Denis J. Villere & Co, an estimated $465K added.
- The largest CollPlant Biotechnologies seller in Q3 2024 was Pinnacle Associates, an estimated $471K sold.
Based on aggregated 13F filings for Q3 2024.